Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) Pfizer USPG **Refrigerated (RX)

Defend against Respiratory Syncytial Virus (RSV) with the Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) by Pfizer USPG—the breakthrough, FDA-approved RSV vaccine for adults and maternal immunization. As recommended by the CDC, Abrysvo delivers advanced protection to high-risk populations, including adults 60+, pregnant women, and individuals with chronic health conditions.

Product Highlights & Top Health Benefits

• Complete RSV Protection: Guards adults, seniors, and pregnant women against severe RSV infection, RSV pneumonia, and RSV-related bronchiolitis.
• Single-Dose Act-O-Vial: Convenient 0.5 mL intramuscular injection, ideal for clinics, hospitals, and healthcare providers.
• Pfizer Quality: Developed by Pfizer USPG, a world leader in vaccines and infectious disease prevention.
• FDA Approved & CDC Recommended: Robust clinical studies support its efficacy and safety for respiratory syncytial virus immunization.
• Maternal RSV Immunization: Protects newborns through passive immunity by vaccinating expectant mothers during pregnancy.
• Senior & High-Risk Vaccination: Designed for adults aged 60 and above, as well as those with underlying conditions such as heart or lung disease.
• Reduces Hospitalizations: Minimizes the risk of hospital visits and severe outcomes due to RSV.

Top Health terms for this Product:

• Abrysvo RSV vaccine
• RSV vaccine for adults
• RSV vaccination for seniors
• Respiratory syncytial virus vaccine
• Pfizer RSV vaccine
• FDA approved RSV vaccine
• CDC recommended RSV vaccine
• RSV vaccine side effects
• Maternal RSV immunization
• Best RSV vaccine for pregnancy
• RSV shot for elderly
• Prevent RSV in infants
• RSV immunization schedule
• Single dose RSV vaccine
• Act-O-Vial RSV vaccine
• Protection from RSV pneumonia
• Vaccine for bronchiolitis prevention
• Adult respiratory vaccines
• Pregnancy vaccines for RSV
• High-risk respiratory immunization

RSV is a leading cause of lower respiratory infections, pneumonia, and hospitalizations among adults 60 and older, people with chronic health conditions, and newborns via maternal transmission. The Abrysvo RSV Vaccine Act-O-Vial is formulated to deliver advanced, season-long protection. By choosing Abrysvo, you’re selecting:

• Cutting-edge RSV prevention for seniors, adults, and expecting mothers.
• Maternal vaccine protection that safeguards both mother and baby from severe RSV.
• Confidence in vaccination with Pfizer’s proven safety, quality, and worldwide trust.
• Alignment with the latest CDC and FDA RSV vaccine guidelines for high-risk patients.

Directions for Use

• Dosage Form: 0.5 mL Act-O-Vial, single intramuscular dose
• Indications: Adults 60+, pregnant women for maternal antibody transfer, and other at-risk individuals as per CDC and FDA guidance
• Administration: By healthcare professional in clinics, hospitals, or physician’s offices
• Storage: Refrigerate; do not freeze.

Safety & Side Effects

The Abrysvo RSV vaccine is well-tolerated and extensively tested. The most common side effects include mild injection site pain, fatigue, headache, and slight swelling—serious reactions are exceedingly rare. Always consult your healthcare provider before vaccination, especially regarding allergies or prior vaccine reactions.

Order Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) Today

Stay protected this RSV season. The Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) by Pfizer USPG is the leading choice for comprehensive RSV immunization in seniors, adults, high-risk groups, and pregnant women seeking to protect their infants. Make Abrysvo part of your immunization program and meet CDC vaccine requirements with confidence.

Buy Abrysvo RSV Vaccine today for industry-leading, FDA-approved protection against the risks of RSV pneumonia, bronchiolitis, and respiratory complications. Trust Pfizer—the name in respiratory health.